title: Scientific Evidence and Financial Obligations to Ensure Access to Biosimilars for Cancer Treatment.
authors.affiliation: Editor in Chief, JAMA.
authors.forename: Howard
authors.initials: H
authors.lastname: Bauchner
authors.affiliation: Executive Editor, JAMA.
authors.forename: Phil B
authors.initials: PB
authors.lastname: Fontanarosa
authors.affiliation: Deputy Editor, JAMA.
authors.forename: Robert M
authors.initials: RM
authors.lastname: Golub
mesh_terms: D059451:Biosimilar Pharmaceuticals / Q000627:therapeutic use*; D017277:Drug Approval; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D014486:United States Food and Drug Administration
chemical_list: D059451:Biosimilar Pharmaceuticals